Evaluating endometrial response to human chorionic gonadotropin: alterations in epigenetic regulation and extracellular vesicle cargo of endometrial stromal cells

In: Human Reproduction Open · 2025 · vol. 2025(3) , pp. hoaf051 · doi:10.1093/hropen/hoaf051 · PMID:40919059 · W4414049754
article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-08

Human chorionic gonadotropin treatment alters endometrial stromal cell epigenetic regulation and extracellular vesicle cargo, influencing implantation and immune response through modified protein and microRNA levels.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

STUDY QUESTION: What is the effect of hCG on the epigenetic profile and the expression of other molecular factors in endometrial stromal cells (ESCs)? SUMMARY ANSWER: Our findings suggest that hCG treatment alters the molecular environment of decidualized ESCs, potentially influencing implantation and immune regulation through epigenetic modifications and changes in the levels of secreted proteins and micro-ribonucleic acids (miRNAs). WHAT IS KNOWN ALREADY: Embryo implantation depends not only on the quality of the embryo but also on the receptivity of the endometrium, the specialized lining of the uterus that undergoes dynamic changes to support pregnancy. Effective communication between the maternal and fetal compartments, facilitated by molecular signals and cellular interactions, is essential for successful implantation. STUDY DESIGN SIZE DURATION: Cross-sectional study of patient-derived ESCs comparing untreated cells with cells treated with hCG and/or decidualization induction. The number of samples depends on the method and varies from 2 to 8. Results were analyzed after 6-, 24-, 48-, and 72-h time-points. PARTICIPANTS/MATERIALS SETTING METHODS: response to the embryo-secreted factor, hCG. ESCs were induced for decidualization for 3 days (medroxyprogesterone acetate+cAMP), or treated with hCG for 24 h, or given combined treatment: 2 days of decidualization followed by 24 h of hCG. Furthermore, we compared decidualized ESCs with decidualized ESCs that were also treated with hCG. We examined various cellular properties, including morphology, metabolic activity, and cell viability of ESCs after induction of decidualization and hCG treatment. Additionally, we assessed changes in the expression of genes associated with decidualization, inflammatory response, apoptosis regulation, and epigenetic factors using RT-qPCR. The levels of histone modifications and the factors regulating these modifications were explored by performing western blot assays. Additionally, we performed a chromatin immunoprecipitation assay to extract gene regions enriched with the epigenetic modification H3K27Ac. Finally, we analyzed the protein and miRNA level changes in ESC extracellular vesicles (ESC-EVs) after the indicated treatments, using mass spectrometry and small RNA sequencing. MAIN RESULTS AND THE ROLE OF CHANCE: < 0.05). LARGE SCALE DATA: N/A. LIMITATIONS REASONS FOR CAUTION: samples. Future studies involving a broader range of cell types and larger sample sizes could help to further validate and expand upon these results. WIDER IMPLICATIONS OF THE FINDINGS: We found that hCG enhances the decidualization process in a dose-dependent manner and affects implantation and immune regulation through epigenetic changes, as well as variations in the levels of secreted proteins and miRNAs. Our study suggests that the application of hCG in assisted reproduction technologies may offer potential benefits for patients. However, carefully considering the appropriate dosage is important to ensure optimal outcomes. STUDY FUNDING/COMPETING INTERESTS: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors have no conflicts of interest to declare.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (65)

Source provenance

openalex
last seen: 2026-05-14T06:28:07.472223+00:00
License: CC0 · commercial use OK